Biomaterials and medical device company Aleo BME has received notification from the U.S. Federal Drug Administration that it has been approved for the sale and licensing of ElaSkinTM as a liquid bandage for the protection and treatment of a broad set of skin conditions and injuries. ElaSkin’sTM development validates Aleo BME’s approach to biopolymer production and characterization […]